REFERENCES
- Burek CL. Autoimmune thyroiditis research at Johns Hopkins University. Immunol Res 2010;47:207–215.
- Damoiseaux JG, Bouten B, Linders AM, . Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002;22:281–288.
- Quinton JF, Sendid B, Reumaux D, . Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788–791.
- Israeli E, Grotto I, Gilburd B, . Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005;54:1232–1236.
- Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies – a novel serologic marker for Behcet’s disease. Clin Exp Rheumatol 2002;20:S21–S24.
- Andretta MA, Vieira TD, Nishiara R, Skare TL. Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis. Rheumatol Int 2011; doi: 10.1007/s00296-010-1722–9.
- Mallant-Hent RCh, Mary B, von Blomberg E, . Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol 2006;18:75–78.
- Toumi D, Mankaï A, Belhadj R, Ghedira-Besbes L, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in coeliac disease. Scand J Gastroenterol 2007;42:821–826.
- Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn’s disease and intestinal tuberculosis. Dig Dis Sci 2007;52:33–39.
- Sakly W, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis. Dig Dis Sci 2008;53:1983–1987.
- Muratori P, Muratori L, Guidi M, . Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003;132:473–476.
- Fagoonee S, De Luca L, De Angelis C, Castelli A, Rizzetto M, Pellicano R. Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis. Minerva Gastroenterol Dietol 2009;55:37–40.
- Sakly W, Mankaï A, Sakly N, . Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes. Endocr Pathol 2010;21:108–114.
- Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus. Lupus 2009;18:1087–1090.
- Mankaï A, Sakly W, Thabet Y, Achour A, Manoubi W, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2012. doi: 10.1007/s00296-012-2431-3.
- Yazıcı D, Aydın SZ, Yavuz D, . Anti-Saccaromyces cerevisiae antibodies (ASCA) are elevated in autoimmune thyroid disease ASCA in autoimmune thyroid disease. Endocrine 2010;38:194–198.
- Mankaï A, Toumi D, Chadli-Chaieb M, . Anti-thyroid-stimulating hormone receptor antibodies determined by second-generation assay. Clin Chem Lab Med 2007;45:26–29.
- D’Incà R, Annese V, di Leo V, . Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn’s disease. Aliment Pharmacol Ther 2006;23:1455–1461.
- Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci 2009;55:1026–1031.
- Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci 2009;1165:195–205.
- Feld JJ, Meddings J, Heathcote EJ. Abnormal intestinal permeability in primary biliary cirrhosis. Dig Dis Sci 2006;51:1607–1613.
- Fresko I, Hamuryudan V, Demir M, . Intestinal permeability in Behçet’s syndrome. Ann Rheum Dis 2001;60:65–66.
- Vaile JH, Meddings JB, Yacyshyn BR, Russell AS, Maksymowych WP. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives. J Rheumatol 1999;26:128–135.
- Fasano A. Systemic autoimmune disorders in celiac disease. Curr Opin Gastroenterol 2006;22:674–679.
- Kawasaki N, Kawasaki T, Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J Biochem (Tokyo) 1983;94:937–947.
- Riis AL, Hansen TK, Thiel S, . Thyroid hormone increases mannan-binding lectin levels. Eur J Endocrinol 2005;153:643–649.
- Sørensen CM, Hansen TK, Steffensen R, Jensenius JC, Thiel S. Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clin Exp Immunol 2006;145:173–182.
- Chazenbalk GD, Pichurin PN, Guo J, Rapoport B, McLachlan SM. Interactions between the mannose receptor and thyroid autoantigens. Clin Exp Immunol 2005;139:216–224.
- Hansen TK, Thiel S, Knudsen ST, . Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab 2003;88:4857–4861.
- Boniotto M, Radillo O, Braida L, . Detection of MBL-2 gene expression in intestinal biopsies of celiac patients by in situ reverse transcription polymerase chain reaction. Eur J Histochem 2003;47:177–180.
- Matsushita M, Miyakawa H, Tanaka A, . Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis. J Autoimmun 2001;17:251–257.
- Tamboli CP, Doman DB, Patel A. Current and future role of biomarkers in Crohn’s disease risk assessment and treatment. Clin Exp Gastroenterol 2011;4:127–140.